Lumizyme / Myozyme

Background

NA

Approved applications

MYOZYME®/LUMIZYME (alglucosidase alfa) is a lysosomal glycogen-specific enzyme indicated for use in patients with Pompe disease (GAA deficiency). Pompe disease is a rare, progressive and often fatal neuromuscular disease. MYOZYME replaces or supplements this enzyme in patients in whom is it is deficient.

Therapeutic Area

Enzyme Replacement Therapy

Acquisition Date

Jan 2011

Marketer